Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer’s Disease: A Systematic Review and Meta-Analysis

Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer’s Disease: A Systematic Review and Meta-Analysis

Neurogranin (Ng) and visinin-like protein 1 (VILIP-1) are promising candidates for Alzheimer’s Disease (AD) biomarkers closely related to synaptic and neuronal degeneration. Both proteins are involved in calcium-mediated pathways. The meta-analysis was performed in random effects based on the ratio...

Full description

Bibliographic Details
Main Authors:	Maciej Dulewicz, Agnieszka Kulczyńska-Przybik, Barbara Mroczko
Format:	Article
Language:	English
Published:	MDPI AG 2020-11-01
Series:	International Journal of Molecular Sciences
Subjects:	Alzheimer’s disease meta-analysis systematic review neurogranin visinin-like-protein-1
Online Access:	https://www.mdpi.com/1422-0067/21/21/8335

Similar Items

Evaluation of Synaptic and Axonal Dysfunction Biomarkers in Alzheimer’s Disease and Mild Cognitive Impairment Based on CSF and Bioinformatic Analysis
by: Maciej Dulewicz, et al.
Published: (2022-09-01)

Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer’s Disease
by: Maciej Dulewicz, et al.
Published: (2021-10-01)

The Relationships between Cerebrospinal Fluid Glial (CXCL12, CX3CL, YKL-40) and Synaptic Biomarkers (Ng, NPTXR) in Early Alzheimer’s Disease
by: Agnieszka Kulczyńska-Przybik, et al.
Published: (2023-08-01)

Association of region‐specific hippocampal reduction of neurogranin with inflammasome proteins in post mortem brains of Alzheimer's disease
by: Regina T. Vontell, et al.
Published: (2024-01-01)

Neurogranin in Alzheimer's disease and ageing: A human post-mortem study
by: Tyler Saunders, et al.
Published: (2023-02-01)

Association of neurogranin gene expression with Alzheimer's disease pathology in the perirhinal cortex
by: Xiaoyan Sun, et al.
Published: (2021-01-01)

CSF VEGF Was Positively Associated with Neurogranin Independent of β-Amyloid Pathology
by: Huang Y, et al.
Published: (2020-07-01)

Neurogranin Regulates Metaplasticity
by: Ling Zhong, et al.
Published: (2020-01-01)

Decreased nesting behavior, selective increases in locomotor activity in a novel environment, and paradoxically increased open arm exploration in Neurogranin knockout mice
by: Ryuichi Nakajima, et al.
Published: (2021-03-01)

Full-length and C-terminal neurogranin in Alzheimer’s disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays
by: Annika Öhrfelt, et al.
Published: (2020-12-01)

VSNL1 Co-expression networks in aging include calcium signaling, synaptic plasticity, and Alzheimer’s disease pathways
by: C W Lin, et al.
Published: (2015-03-01)

Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke
by: Ann De Vos, et al.
Published: (2017-08-01)

Neurogranin and Neurofilament Light Chain as Preclinical Biomarkers in Scrapie
by: Marina Betancor, et al.
Published: (2022-06-01)

Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase
by: Bruno Becker, et al.
Published: (2018-08-01)

Neurogranin: A Potential Biomarker of Neurological and Mental Diseases
by: Yang Xiang, et al.
Published: (2020-10-01)

Biomarkers for the Diagnosis of Alzheimer’s Disease in Clinical Practice: The Role of CSF Biomarkers during the Evolution of Diagnostic Criteria
by: Maciej Dulewicz, et al.
Published: (2022-08-01)

The Implication of Reticulons (RTNs) in Neurodegenerative Diseases: From Molecular Mechanisms to Potential Diagnostic and Therapeutic Approaches
by: Agnieszka Kulczyńska-Przybik, et al.
Published: (2021-04-01)

Neurogranin expression regulates mitochondrial function and redox balance in endothelial cells
by: Ashton N. Jorgensen, et al.
Published: (2024-04-01)

Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer’s Disease from Other Neurological Disorders
by: Tommaso Piccoli, et al.
Published: (2022-09-01)

Neurogranin as an important regulator in swimming training to improve the spatial memory dysfunction of mice with chronic cerebral hypoperfusion
by: Huawei Lin, et al.
Published: (2023-01-01)

Neurogranin regulates eNOS function and endothelial activation
by: Vino T. Cheriyan, et al.
Published: (2020-07-01)

Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer’s Disease
by: Julia Doroszkiewicz, et al.
Published: (2023-07-01)

Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1–42)/Aβ(1–40)
by: Hugo Vanderstichele, et al.
Published: (2017-06-01)

Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias
by: Giuseppe Mario Bentivenga, et al.
Published: (2023-09-01)

Neurogranin Regulates Adult-Born Olfactory Granule Cell Spine Density and Odor-Reward Associative Memory in Mice
by: Simona Gribaudo, et al.
Published: (2021-04-01)

Fatty Acid Binding Protein 3 (FABP3) and Apolipoprotein E4 (ApoE4) as Lipid Metabolism-Related Biomarkers of Alzheimer’s Disease
by: Maciej Dulewicz, et al.
Published: (2021-07-01)

Association of Clusterin Levels in Cerebrospinal Fluid with Synaptic Degeneration Across the Alzheimer’s Disease Continuum
by: Wang J, et al.
Published: (2020-01-01)

Effects of a n-3 PUFA deficient diet on the expression of retinoid nuclear receptors, neurogranin and neuromodulin in rat brain
by: Buaud Benjamin, et al.
Published: (2007-05-01)

The past and the future of Alzheimer’s disease CSF biomarkers – a journey towards validated biochemical tests covering the whole spectra of molecular events
by: Kaj eBlennow
Published: (2015-09-01)

The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases
by: Agnieszka Kulczyńska-Przybik, et al.
Published: (2021-11-01)

Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum
by: Julie Goossens, et al.
Published: (2023-10-01)

Visinin‐like 1, a novel target gene of the Wnt/β‐catenin signaling pathway, is involved in apoptosis resistance in colorectal cancer
by: Hiroki Tage, et al.
Published: (2023-06-01)

Molecular biomarkers of Alzheimer's disease: progress and prospects
by: Tammaryn Lashley, et al.
Published: (2018-05-01)

Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course—a joint PhD student course at University College London and University of Gothenburg
by: Pawel Obrocki, et al.
Published: (2020-02-01)

Meta-analysis and systematic review of peripheral platelet-associated biomarkers to explore the pathophysiology of alzheimer's disease
by: Jiajia Fu, et al.
Published: (2023-02-01)

Serum Amyloid Beta Precursor Protein, Neurofilament Light, and Visinin-like Protein-1 in Rugby Players: An Exploratory Study
by: Jessica E. Morgan, et al.
Published: (2022-11-01)

Serum Visinin-Like Protein 1 Is a Better Biomarker Than Neuron-Specific Enolase for Seizure-Induced Neuronal Injury: A Prospective and Observational Study
by: Zheren Tan, et al.
Published: (2020-09-01)

Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer’s disease
by: Madhurima Chatterjee, et al.
Published: (2018-06-01)

Comparative Analysis of Neurodegeneration and Axonal Dysfunction Biomarkers in the Cerebrospinal Fluid of Patients with Multiple Sclerosis
by: Agnieszka Kulczyńska-Przybik, et al.
Published: (2022-07-01)

Amyloid and Tau Protein Concentrations in Children with Meningitis and Encephalitis
by: Artur Sulik, et al.
Published: (2022-03-01)